default author photo

Ulrike Leiter

University of Tübingen

Tübingen, 72074

Germany

SCHOLARLY PAPERS

4

DOWNLOADS

199

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Nomogram for Predicting Survival after First-Line Anti-Pd-1 Immunotherapy in Unresectable Stage IV Melanoma: A Multicenter International Study

Number of pages: 29 Posted: 21 Dec 2023
University of Tübingen, University of Tübingen, Charité - Universitätsmedizin Berlin, Military Medical Academy of Belgrade, Military Medical Academy of Belgrade, Dresden University of Technology, Kantonsspital St Gallen, Hospital Universitario Gregorio Marañón, Centro Hospitalar e Universitário do Algarve, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen - Centre for Dermatooncology, University Clinical Centre of Serbia, University Clinical Centre of Serbia, Dresden University of Technology, Charité - Universitätsmedizin Berlin, University of Tübingen, University of Tübingen, University of Tübingen and University of Tübingen - Centre for Dermatooncology
Downloads 88 (765,566)

Abstract:

Loading...

nomogram, melanoma, survival, checkpoint inhibitors, anti-PD-1, first line, stage IV

2.

Identification of Stage I and II Melanoma Patients at High Risk for Recurrence Using a Model Combining Clinicopathologic Factors with Gene Expression Profiling (CP-GEP)

Number of pages: 19 Posted: 30 Nov 2022
University of Tübingen - Centre for Dermatooncology, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, SkylineDx BV, SkylineDx BV, SkylineDx BV, University of Tübingen, Princess Máxima Center for Pediatric Oncology and University of Tübingen
Downloads 55 (1,010,164)

Abstract:

Loading...

early stage melanoma, CP-GEP, biomarkers, adjuvant therapy, risk stratification

3.

Enhanced Overall and Progression-Free Survival in Advanced Melanoma Patients undergoing Targeted Therapy alongside Antithrombotic Treatment – Insights from a Multicenter Study involving 1,296 Patients from the Prospective Skin Cancer Registry ADOReg

Number of pages: 26 Posted: 31 Oct 2025
University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Kiel, affiliation not provided to SSRN, University of Tübingen, University Hospital Erlangen, University Hospital Mühlenkreiskliniken Minden, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN, Elbe Kliniken Buxtehude, affiliation not provided to SSRN, Helios Klinikum Erfurt, Heidelberg University - Department of Dermatology, affiliation not provided to SSRN, Universitat Regensburg, Saarland University - Medical School, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Freiburg, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf and University Medical Center Hamburg- Eppendorf
Downloads 31 (1,304,549)

Abstract:

Loading...

melanoma, targeted therapy, BRAF and MEK inhibitors, Anticoagulation, Direct oral anticoagulants (DOACs), Factor Xa inhibitors, Progression-free survival (PFS), Overall survival (OS), Platelet aggregation inhibition, Venous thromboembolism (VTE), Immunothrombosis

4.

Sex-Specific Survival in Advanced Metastatic Melanoma – a Decog Study on 2032 Patients of the Multicenter Prospective Skin Cancer Registry Adoreg

Number of pages: 24 Posted: 06 Jun 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Schleswig-Holstein University, Elbe Kliniken Buxtehude, Dresden University of Technology, affiliation not provided to SSRN, University Hospital Mühlenkreiskliniken Minden, Heidelberg University - Department of Dermatology, University of Lubeck, Helios Klinikum Erfurt, University Hospital Regensburg, Saarland University - Medical School, University of Tübingen, University of Tübingen, University of Witten/Herdecke - Witten/Herdecke University Hospital, University Medical Center Hamburg- Eppendorf, affiliation not provided to SSRN, Universitätsklinikum Münster, affiliation not provided to SSRN, Paracelsus Medical University Nuremberg - General Hospital Nuremberg, Heidelberg University - University Hospital Heidelberg, University Hospital Augsburg, Ludwig Maximilian University of Munich (LMU), University Hospital Erlangen, affiliation not provided to SSRN, affiliation not provided to SSRN, Leipzig University, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 25 (1,385,945)

Abstract:

Loading...

Melanoma, sex, Targeted therapy, immune checkpoint inhibition therapy, Survival